Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSII and Oral Hypoglycemics on Testosterone in T2DM
NCT03982238Phase 4Completed
- Sponsor
- Majianhua
- Start
- Jun 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metformin and dapagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Majianhua. Started Jun 2019; status: completed.
02
Drugs
metformindapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03982238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03982238.